Celsis rapid microbial detection methods from Charles River

« Previous article
Chembio Loses FDA EU...

23rd June 2020  Content supplied by: SeraCare Life Sciences, Inc.

LGC SeraCare Expands SARS-CoV-2 Serology Offering with 11-Member, Positive-Patient Performance Panel

LGC SeraCare has released the AccuSet™ SARS-CoV-2 Performance Panel (material #0820-0410), intended for use by clinical laboratories and diagnostic manufacturers alike, to evaluate SARS-CoV-2 antibody assays. 

This eleven-member validation panel contains highly characterized, true patient specimens, offering an out-of-the-box solution to provide confidence, mitigate sourcing challenges and accelerate antibody assay development, validation, verification and onboarding.

Comprised of undiluted, naturally occurring human plasma samples, this panel demonstrates a range of SARS-CoV-2 antibody reactivity. Ten panel members represent collections from multiple individuals positive for antibodies to SARS-CoV-2; a single negative member is also included. A comprehensive data sheet, generated using commercially available SARS-CoV-2 antibody assays, is provided for comparative analysis.

To order your performance panel and gain confidence in your assay, and to learn more about the AccuSet SARS-CoV-2 Performance Panel, and the complete line of SARS-CoV-2 Quality Solutions, please visit the LGC SeraCare website or if you need further information use the 'Request Information' button provided below. 



Date Published: 23rd June 2020

Source article link: View

View full company details